Core Viewpoint - The company has made progress in its fundraising projects, with some completed and others still under construction, while focusing on expanding its proprietary brand business under the "extreme antibody" strategy [1] Group 1: Fundraising Projects - Some fundraising projects have been completed, while others are still in the construction phase [1] - Investors can track the progress of these projects through the company's past and future annual and semi-annual reports [1] Group 2: Proprietary Brand Business - The company aims for over 20% growth in its proprietary brand business by the first half of 2025, with an increasing revenue share from these products [1] - The company has enriched its proprietary product offerings, with over 4,200 SPUs developed at the Hangzhou antibody research center and over 1,800 SPUs at the Nanjing protein research center [1] - Future efforts will focus on maintaining stability in third-party brand business while expanding the market for proprietary brands to improve revenue structure and enhance sustainable development capabilities [1]
优宁维：公司募投项目中部分已结项，部分尚在投入建设过程中